NovaSOL Curcumin

NovaSOL Curcumin is a highly bioavailable curcumin formulation utilizing proprietary micellar solubilization nanotechnology developed by Aquanova AG. The formulation converts curcumin extract into liquid micelles, creating a stable aqueous dispersion that dramatically enhances absorption. This technology increases curcumin bioavailability up to **185-fold** compared to native curcumin powder, with a 453-fold increase in maximum plasma concentration (Cmax)[1][2]. The formulation achieves significantly faster absorption with a Tmax of 1.1 hours versus 7.5 hours for native curcumin[2]. NovaSOL Curcumin consists of 95% pure curcuminoids processed from natural Curcuma longa extract[5]. The formulation has been validated in four gold-standard human clinical trials and has GRAS (Generally Recognized as Safe) status[5]. Curcumin exhibits antioxidant and anti-inflammatory properties, primarily through inhibition of cyclooxygenase-2 (COX-2), prostaglandins, leukotrienes, and pro-inflammatory cytokines[4]. The formulation is indicated for supporting joint health, cognitive function, cardiovascular health, immune system function, and managing inflammatory conditions[1][5].

Brand names

NovaSOL CurcuminMST Curcumin NovaSOL

Other names

NovaSOL® CurcuminCurcumin NovaSOL